COX-2 inhibitors vs. NSAIDs in gastrointestinal damage and prevention

By Ballinger A.   Smith G.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 1, 2001-01 ,pp. : 31-40

Informa Healthcare

Access to resources Recommend Favorite

Factors that Influence Prescribers in their Selection and use of COX-2 Selective Inhibitors as Opposed to Non-selective NSAIDs*

By Gunnarsdóttir Anna   Kinnear Moira  

Pharmacy World and Science, Vol. 27, Iss. 4, 2005-08 ,pp. : 316-320

Springer Publishing Company

Access to resources Recommend Favorite

Value of Information in the Osteoarthritis Setting: Cost Effectiveness of COX-2 Selective Inhibitors, Traditional NSAIDs and Proton Pump Inhibitors

By Latimer Nicholas  

PharmacoEconomics, Vol. 29, Iss. 3, 2011-03 ,pp. : 225-237

Adis International

Access to resources Recommend Favorite

Temporal Relationship between Use of NSAIDs, Including Selective COX-2 Inhibitors, and Cardiovascular Risk

By Motsko Stephen P.  

Drug Safety, Vol. 29, Iss. 7, 2006-01 ,pp. : 621-632

Adis International

Access to resources Recommend Favorite

Selective COX-2 inhibitors may pose a greater risk of hyperkalaemia than nonselective NSAIDs

By  

Reactions Weekly, Vol. 1, Iss. 1325, 2010-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite